# LASMIDITAN
> **ANDA219350** · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARMACEUTICAL CO., LTD. · Approved 2024-12-20
## Drug
- **FDA Application Number:** ANDA219350
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LASMIDITAN
- **Generic name:** Lasmiditan
- **Active ingredients:** LASMIDITAN
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** QILU PHARMACEUTICAL CO., LTD.
- **First approval:** 2024-12-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219350)
---
*AI Analytics · CC0 1.0*